Streetbeat News

Analyst Ratings

AMAL

JP Morgan analyst Steven Alexopoulos maintains a Neutral rating on Amalgamated Financial (NASDAQ:AMAL) and raises the price target from $22 to $24.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 7:49 pm

AER

JP Morgan analyst Jamie Baker maintains an Overweight rating on AerCap Holdings (NYSE:AER) and raises the price target from $77 to $80.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 7:47 pm

FNWB

Piper Sandler analyst Jeffrey Kitsis maintains a Neutral rating on First Northwest Bancorp (NASDAQ:FNWB) and lowers the price target from $14 to $13.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 7:42 pm

LUNG

Piper Sandler analyst Jason Bednar has maintained an Overweight rating on Pulmonx (NASDAQ:LUNG) but lowered the price target from $17 to $13.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 7:40 pm

AXNX

Piper Sandler analyst Adam Maeder maintains an Overweight rating on Axonics (NASDAQ:AXNX) but has lowered the price target from $84 to $75.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 7:36 pm

LHX

L3Harris Technologies' stock has been upgraded from Neutral to Outperform by Baird, which also raised its price target from $198 to $216. This has resulted in the shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 7:33 pm

VFC

Piper Sandler analyst Abbie Zvejnieks maintains a Neutral rating on VF (NYSE:VFC) and lowers the price target from $20 to $18.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 7:31 pm

DE

A whale investor has taken a bullish stance on Deere (NYSE:DE), with 60% of the investors opening trades with bullish expectations and 40% with bearish. The whale has been targeting a price range from $310.0 to $400.0 for Deere over the last 3 months. Currently, the price of DE is down -0.73% at $365.11.

Portfolio Pulse from Benzinga Insights

October 31, 2023 | 7:31 pm

CHKP

Check Point Software Technologies' shares are trading higher after BMO Capital maintained a Market Perform rating on the stock and raised its price target from $140 to $142.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 7:31 pm

CVS

A significant investor has taken a bearish stance on CVS Health (NYSE:CVS), with 100% of the detected 15 unusual trades being bearish. The trades include 9 puts worth $342,329 and 6 calls worth $196,561. The targeted price range for CVS Health over the last 3 months is from $45.0 to $75.0. The price of CVS is currently up 1.44% at $68.99, and the next earnings are expected to be released in 1 day.

Portfolio Pulse from Benzinga Insights

October 31, 2023 | 7:30 pm